Literature DB >> 8163785

Regulation of IgE and IgG4 responses by allergen specific T-cell clones to bee venom phospholipase A2 in vitro.

J M Carballido1, N Carballido-Perrig, A Oberli-Schrämmli, C H Heusser, K Blaser.   

Abstract

An in vitro antibody response to bee venom phospholipase A2 (PLA) from peripheral blood mononuclear cells of bee sting-sensitized individuals was achieved after stimulation with PLA and pokeweed mitogen. This stimulation resulted in a secretion of TH1-associated cytokines and induced PLA-specific and nonspecific IgG4 antibody production but not IgE production. The addition of interleukin-4 (IL-4) to this system decreased the secretion of IgG antibodies, whereas secretion of polyspecific IgE was induced. The mitogen was not required if peripheral blood mononuclear cells were enriched with autologous, PLA-specific, resting T-cell clones in the presence of the antigen. In these experiments the cytokine profile of the particular clone determined the antibody class generated. Low ratios of IL-4 to interferon-gamma, induced by the antigen alone or obtained by neutralizing anti-IL-4 antibodies, enhanced IgG4 antibody formation, whereas IgE levels increased at high ratios of IL-4 to interferon-gamma. These results suggest a complementary regulation of the main isotypes, IgE and IgG4, implicated in allergic and protective hyperimmune responses.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8163785     DOI: 10.1016/0091-6749(94)90256-9

Source DB:  PubMed          Journal:  J Allergy Clin Immunol        ISSN: 0091-6749            Impact factor:   10.793


  9 in total

1.  Analysis of immunoglobulin E VH transcripts in a bronchial biopsy of an asthmatic patient confirms bias towards VH5, and indicates local clonal expansion, somatic mutation and isotype switch events.

Authors:  R E Snow; R Djukanovic; F K Stevenson
Journal:  Immunology       Date:  1999-12       Impact factor: 7.397

Review 2.  Hymenoptera venom allergens.

Authors:  Donald R Hoffman
Journal:  Clin Rev Allergy Immunol       Date:  2006-04       Impact factor: 8.667

3.  Different natural killer (NK) receptor expression and immunoglobulin E (IgE) regulation by NK1 and NK2 cells.

Authors:  E Aktas; M Akdis; S Bilgic; R Disch; C S Falk; K Blaser; C Akdis; G Deniz
Journal:  Clin Exp Immunol       Date:  2005-05       Impact factor: 4.330

4.  Reduced efficacy of treatment of strongyloidiasis in HTLV-I carriers related to enhanced expression of IFN-gamma and TGF-beta1.

Authors:  M Satoh; H Toma; Y Sato; M Takara; Y Shiroma; S Kiyuna; K Hirayama
Journal:  Clin Exp Immunol       Date:  2002-02       Impact factor: 4.330

5.  Epitope-specific T cell tolerance to phospholipase A2 in bee venom immunotherapy and recovery by IL-2 and IL-15 in vitro.

Authors:  C A Akdis; M Akdis; T Blesken; D Wymann; S S Alkan; U Müller; K Blaser
Journal:  J Clin Invest       Date:  1996-10-01       Impact factor: 14.808

6.  Role of interleukin 10 in specific immunotherapy.

Authors:  C A Akdis; T Blesken; M Akdis; B Wüthrich; K Blaser
Journal:  J Clin Invest       Date:  1998-07-01       Impact factor: 14.808

7.  Human dendritic cells transfected with allergen-DNA stimulate specific immunoglobulin G4 but not specific immunoglobulin E production of autologous B cells from atopic individuals in vitro.

Authors:  Bettina König; Arnd Petersen; Iris Bellinghausen; Ingo Böttcher; Wolf-Meinhard Becker; Jürgen Knop; Joachim Saloga
Journal:  Immunology       Date:  2007-10       Impact factor: 7.397

8.  Biophysical and Functional Characterization of Rhesus Macaque IgG Subclasses.

Authors:  Austin W Boesch; Nana Yaw Osei-Owusu; Andrew R Crowley; Thach H Chu; Ying N Chan; Joshua A Weiner; Pranay Bharadwaj; Rufus Hards; Mark E Adamo; Scott A Gerber; Sarah L Cocklin; Joern E Schmitz; Adam R Miles; Joshua W Eckman; Aaron J Belli; Keith A Reimann; Margaret E Ackerman
Journal:  Front Immunol       Date:  2016-12-13       Impact factor: 7.561

9.  Assessment of tumor growth factor-β1 neutralizing antibody in the treatment of allergic rhinitis and asthma.

Authors:  Yan Wei; Zhili Zhang; Feng Wang; Shuihong Zhou
Journal:  Exp Ther Med       Date:  2017-11-13       Impact factor: 2.447

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.